DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,120,001 | +3.1% | 4,514 | -0.3% | 0.09% | +2.2% |
| Q2 2023 | $1,086,417 | +134.3% | 4,527 | +146.0% | 0.09% | +114.3% |
| Q1 2023 | $463,670 | -47.5% | 1,840 | -44.7% | 0.04% | -55.3% |
| Q4 2022 | $882,522 | -43.0% | 3,325 | -44.5% | 0.09% | -51.8% |
| Q3 2022 | $1,549,000 | +76.2% | 5,996 | +72.9% | 0.20% | +42.3% |
| Q2 2022 | $879,000 | -18.2% | 3,467 | -5.4% | 0.14% | +7.0% |
| Q1 2022 | $1,075,000 | +59.7% | 3,665 | +79.1% | 0.13% | +113.3% |
| Q4 2021 | $673,000 | +24.9% | 2,046 | +15.6% | 0.06% | +11.1% |
| Q3 2021 | $539,000 | +13.5% | 1,770 | 0.0% | 0.05% | +10.2% |
| Q2 2021 | $475,000 | +19.3% | 1,770 | 0.0% | 0.05% | +2.1% |
| Q1 2021 | $398,000 | +1.3% | 1,770 | 0.0% | 0.05% | -9.4% |
| Q4 2020 | $393,000 | -17.8% | 1,770 | -20.3% | 0.05% | -27.4% |
| Q3 2020 | $478,000 | +21.6% | 2,221 | 0.0% | 0.07% | 0.0% |
| Q2 2020 | $393,000 | +60.4% | 2,221 | +25.5% | 0.07% | +9.0% |
| Q1 2020 | $245,000 | -9.9% | 1,770 | 0.0% | 0.07% | -20.2% |
| Q4 2019 | $272,000 | -15.3% | 1,770 | -20.3% | 0.08% | -16.0% |
| Q3 2019 | $321,000 | +1.3% | 2,221 | 0.0% | 0.10% | 0.0% |
| Q2 2019 | $317,000 | +8.2% | 2,221 | 0.0% | 0.10% | +4.2% |
| Q1 2019 | $293,000 | +27.9% | 2,221 | 0.0% | 0.10% | +12.9% |
| Q4 2018 | $229,000 | -5.0% | 2,221 | 0.0% | 0.08% | +11.8% |
| Q3 2018 | $241,000 | +3.9% | 2,221 | -5.3% | 0.08% | +10.1% |
| Q2 2018 | $232,000 | +0.9% | 2,346 | 0.0% | 0.07% | 0.0% |
| Q1 2018 | $230,000 | +5.5% | 2,346 | 0.0% | 0.07% | +16.9% |
| Q4 2017 | $218,000 | – | 2,346 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |